Targeting A3 and A2A adenosine receptors in the fight against cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 13, 2019 Category: Drugs & Pharmacology Authors: Stefania Merighi Enrica Battistello Luca Giacomelli Katia Varani Fabrizio Vincenzi Pier Andrea Borea Stefania Gessi Source Type: research

A preclinical overview of emerging therapeutic targets for glomerular diseases
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 13, 2019 Category: Drugs & Pharmacology Authors: Paola Cassis Carlamaria Zoja Luca Perico Giuseppe Remuzzi Source Type: research

Targeting A3 and A2A adenosine receptors in the fight against cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 13, 2019 Category: Drugs & Pharmacology Authors: Stefania Merighi Enrica Battistello Luca Giacomelli Katia Varani Fabrizio Vincenzi Pier Andrea Borea Stefania Gessi Source Type: research

A preclinical overview of emerging therapeutic targets for glomerular diseases
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 13, 2019 Category: Drugs & Pharmacology Authors: Paola Cassis Carlamaria Zoja Luca Perico Giuseppe Remuzzi Source Type: research

Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targets.
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 10, 2019 Category: Drugs & Pharmacology Authors: John W. Hanrahan Yukiko Sato Graeme W. Carlile Gregor Jansen Jason C. Young David Y. Thomas Source Type: research

Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 10, 2019 Category: Drugs & Pharmacology Authors: Ma ïka Jangal Benjamin Lebeau Michael Witcher Source Type: research

Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targets.
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 10, 2019 Category: Drugs & Pharmacology Authors: John W. Hanrahan Yukiko Sato Graeme W. Carlile Gregor Jansen Jason C. Young David Y. Thomas Source Type: research

Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 10, 2019 Category: Drugs & Pharmacology Authors: Ma ïka Jangal Benjamin Lebeau Michael Witcher Source Type: research

Correction
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 8, 2019 Category: Drugs & Pharmacology Source Type: research

Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 6, 2019 Category: Drugs & Pharmacology Authors: Rajan Patel Jeffrey I. Traylor Khatri Latha Amy B. Heimberger Shulin Li Ganesh Rao Source Type: research

Targeting fusion proteins: a double edge sword?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 6, 2019 Category: Drugs & Pharmacology Authors: Oscar M. Tirado Source Type: research

Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 6, 2019 Category: Drugs & Pharmacology Authors: Rajan Patel Jeffrey I. Traylor Khatri Latha Amy B. Heimberger Shulin Li Ganesh Rao Source Type: research

Targeting fusion proteins: a double edge sword?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 6, 2019 Category: Drugs & Pharmacology Authors: Oscar M. Tirado Source Type: research

ASCT2: a potential cancer drug target
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 5, 2019 Category: Drugs & Pharmacology Authors: Kanu Wahi Jeff Holst Source Type: research

Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 3, 2019 Category: Drugs & Pharmacology Authors: Annabelle M. Warren S øren T. Knudsen Mark E. Cooper Source Type: research

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 24, 2019 Category: Drugs & Pharmacology Authors: Marcelino Bermudez-Lopez Carles Forne Nuria Amigo Milica Bozic David Arroyo Teresa Bretones Nuria Alonso Serafi Cambray Maria Dolores Del Pino Didac Mauricio Jose Luis Gorriz Elvira Fernandez Jose Manuel Valdivielso Source Type: research

Shedding light on RNaseH: a promising target for hepatitis B virus (HBV)
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 23, 2019 Category: Drugs & Pharmacology Authors: Tiffany C. Edwards Nathan L. Ponzar John E. Tavis Source Type: research

Visfatin as a therapeutic target for rheumatoid arthritis
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 15, 2019 Category: Drugs & Pharmacology Authors: Eloi Franco-Trepat Ana Alonso-P érez Mar ía Guillán-Fresco Alberto Jorge-Mora Oreste Gualillo Juan J. G ómez-Reino Rodolfo G ómez Bahamonde Source Type: research

Genome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteria
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 15, 2019 Category: Drugs & Pharmacology Authors: Nikolet Pavlova Robert Penchovsky Source Type: research

Molecular links between COPD and lung cancer: new targets for drug discovery?
Volume 23, Issue 6, June 2019, Page 539-553 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 12, 2019 Category: Drugs & Pharmacology Authors: Gaetano Caramori Paolo Ruggeri Sharon Mumby Antonio Ieni Federica Lo Bello Vrushali Chimankar Chantal Donovan Filippo And ò Francesco Nucera Irene Coppolino Giovanni Tuccari Philip M. Hansbro Ian M. Adcock Source Type: research

The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension
Volume 23, Issue 6, June 2019, Page 511-524 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 12, 2019 Category: Drugs & Pharmacology Authors: Thomas Bertero Dror Perk Stephen Y. Chan Source Type: research

Molecular links between COPD and lung cancer: new targets for drug discovery?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 12, 2019 Category: Drugs & Pharmacology Authors: Gaetano Caramori Paolo Ruggeri Sharon Mumby Antonio Ieni Federica Lo Bello Vrushali Chaminka Chantal Donovan Filippo And ò Francesco Nucera Irene Coppolino Giovanni Tuccari Philip M. Hansbro Ian M. Adcock Source Type: research

Genome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteria
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 11, 2019 Category: Drugs & Pharmacology Authors: Nikolet Pavlova Robert Penchovsky Source Type: research

Aberrant lipid metabolism as a therapeutic target in liver cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 11, 2019 Category: Drugs & Pharmacology Authors: Evans D. Pope Erinmarie O. Kimbrough Lalitha Padmanabha Vemireddy Phani Keerthi Surapaneni John A. Copland Kabir Mody Source Type: research

Visfatin as a therapeutic target for rheumatoid arthritis
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 10, 2019 Category: Drugs & Pharmacology Authors: Eloi Franco-Trepat Ana Alonso-P érez Mar ía Guillán-Fresco Alberto Jorge-Mora Oreste Gualillo Juan J. G ómez-Reino Rodolfo G ómez Bahamonde Source Type: research

The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 4, 2019 Category: Drugs & Pharmacology Authors: Thomas Bertero Dror Perk Stephen Y. Chan Source Type: research

Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 25, 2019 Category: Drugs & Pharmacology Authors: Henriette Farkas Source Type: research

Emerging strategies to target the dysfunctional cohesin complex in cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 25, 2019 Category: Drugs & Pharmacology Authors: Konstantinos Mintzas Michael Heuser Source Type: research

Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 25, 2019 Category: Drugs & Pharmacology Authors: Nicolas Melis Raphael Thuillier Clara Steichen Sebastien Giraud Yse Sauvageon Jacques Kaminski Thomas Pel é Lionel Badet Jean Pierre Richer Jonatan Barrera-Chimal Fr édéric Jaisser Michel Tauc Thierry Hauet Source Type: research

Emerging strategies to target the dysfunctional cohesin complex in cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 25, 2019 Category: Drugs & Pharmacology Authors: Konstantinos Mintzas Michael Heuser Source Type: research

Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 25, 2019 Category: Drugs & Pharmacology Authors: Henriette Farkas Source Type: research

TIPE2 as a potential therapeutic target in chronic viral hepatitis
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 17, 2019 Category: Drugs & Pharmacology Authors: Jian Ji Yuan-Yuan Zhang Yu-Chen Fan Source Type: research

Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 16, 2019 Category: Drugs & Pharmacology Authors: Keisaku Sato Shannon Glaser Lindsey Kennedy Suthat Liangpunsakul Fanyin Meng Heather Francis Gianfranco Alpini Source Type: research

Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma
Volume 23, Issue 5, May 2019, Page 393-406 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 16, 2019 Category: Drugs & Pharmacology Authors: Helmut Denk Conny Stumptner Peter M. Abuja Kurt Zatloukal Source Type: research

Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 16, 2019 Category: Drugs & Pharmacology Authors: Keisaku Sato Shannon Glaser Lindsey Kennedy Suthat Liangpunsakul Fanyin Meng Heather Francis Gianfranco Alpini Source Type: research

Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 16, 2019 Category: Drugs & Pharmacology Authors: Helmut Denk Conny Stumptner Peter M. Abuja Kurt Zatloukal Source Type: research

The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer
Volume 23, Issue 5, May 2019, Page 365-367 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 15, 2019 Category: Drugs & Pharmacology Authors: Rowa Bakadlag Pouria Jandaghi J örg D. Hoheisel Yasser Riazalhosseini Source Type: research

The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 15, 2019 Category: Drugs & Pharmacology Authors: Rowa Bakadlag Pouria Jandaghi J örg D. Hoheisel Yasser Riazalhosseini Source Type: research

Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells
Volume 23, Issue 5, May 2019, Page 447-456 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 2, 2019 Category: Drugs & Pharmacology Authors: Amin Kamrani Amir Mehdizadeh Majid Ahmadi Leili Aghebati-Maleki Mehdi Yousefi Source Type: research

Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 2, 2019 Category: Drugs & Pharmacology Authors: Amin Kamrani Amir Mehdizadeh Majid Ahmadi Leili Aghebati-Maleki Mehdi Yousefi Source Type: research

TANK-binding kinase 1 as a novel therapeutic target for viral diseases
Volume 23, Issue 5, May 2019, Page 437-446 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 1, 2019 Category: Drugs & Pharmacology Authors: Chunyuan Zhao Wei Zhao Source Type: research

Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress
Volume 23, Issue 5, May 2019, Page 369-377 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 1, 2019 Category: Drugs & Pharmacology Authors: Toshiki Kijima Thomas Prince Len Neckers Fumitaka Koga Yasuhisa Fujii Source Type: research